2.05
Tscan Therapeutics Inc Stock (TCRX) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
92.15%
0.566
|
7.211 | 3.887 | 3.148 | 6.803 |
|
11.80%
31.94
|
28.57 | 28.64 | 27.76 | 29.55 |
Interest Income/Expense |
12.56%
0.959
|
0.852 | 0.982 | 0.969 | 0.956 |
Benefits Costs and Expenses |
14.48%
30.71
|
26.82 | - | - | 29.37 |
Costs And Expenses |
14.48%
30.71
|
26.82 | 28.64 | 27.76 | 29.37 |
Operating Income/Loss |
46.90%
-31.37
|
-21.36 | -24.75 | -24.61 | -22.74 |
Income/Loss From Continuing Operations Before Tax |
53.68%
-30.14
|
-19.61 | 3.887 | 3.148 | -22.56 |
Income/Loss From Continuing Operations After Tax |
53.68%
-30.14
|
-19.61 | -23.00 | -24.05 | -22.56 |
|
53.68%
-30.14
|
-19.61 | -23.00 | -24.05 | -22.56 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
859.45%
94.88
|
9.8886 | 94.83 | 47.21 | 24.23 |
Diluted Average Shares |
859.45%
94.88
|
9.8886 | 94.83 | 47.21 | 24.23 |
Basic Earnings Per Share |
190.91%
-0.32
|
-0.11 | -0.24 | -0.51 | -0.93 |
Diluted Earnings Per Share |
190.91%
-0.32
|
-0.11 | -0.24 | -0.51 | -0.93 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):